BRISTOL-MYERS SQUIBB COMPANY Liability, Defined Benefit Plan, Current
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Liability, Defined Benefit Plan, Current of $40.00 million as of 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Notes › Payables and Accruals › Employee-related Liabilities, Current
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities · last filed 2018-10-25
- 2018-09-30: Liability, Defined Benefit Plan, Current $40.00M.
- 2018-06-30: Liability, Defined Benefit Plan, Current $40.00M.
- 2018-03-31: Liability, Defined Benefit Plan, Current $40.00M.
- 2017-12-31: Liability, Defined Benefit Plan, Current $40.00M.
| Period end | Liability, Defined Benefit Plan, Current |
|---|---|
| 2018-09-30 | $40.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $40.00M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $40.00M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $40.00M 10-Q · filed 2018-10-25 |
| 2017-09-30 | $41.00M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $41.00M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $41.00M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $44.00M 10-K · filed 2018-02-13 |
| 2016-09-30 | $47.00M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $47.00M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $47.00M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $47.00M 10-K · filed 2017-02-21 |
| 2014-12-31 | $47.00M 10-K · filed 2016-02-12 |
| 2013-12-31 | $47.00M 10-K · filed 2015-02-13 |
| 2012-12-31 | $49.00M 10-K · filed 2014-02-14 |
| 2011-12-31 | $46.00M 10-K · filed 2013-02-15 |
| 2010-12-31 | $47.00M 10-K · filed 2012-02-17 |
| 2009-12-31 | $43.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |